Trial Profile
Placenta Accreta : Contrast-enhanced Ultrasound Analysis in High Risk Population
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Dec 2016
Price :
$35
*
At a glance
- Drugs Sulfur hexafluoride (Primary)
- Indications Placental disorders
- Focus Diagnostic use
- 05 Dec 2016 Status changed from recruiting to completed.
- 03 Dec 2014 New trial record